---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-23-027839"
form_type: "8-K"
ticker: "MED"
cik: "0000910329"
company_name: "MEDIFAST INC"
filed_at: "2023-08-07T23:59:59+00:00"
generated_at: "2026-06-12T05:26:12.596317+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Medifast Q2 revenue falls 34.7% to $296.2M; diluted EPS $2.77 vs $3.42

## Summary
- Revenue $296.2M (-34.7%); net income $30.3M, EPS $2.77 vs $39.1M, $3.42 prior.
- Active earning OPTA VIA coaches down 21.9% to 53,100; revenue per coach $5,578.
- Q3 2023 guidance: revenue $220-$240M, diluted EPS $0.71-$1.32, tax rate 23-25%.
- Cash $147.4M, no debt; quarterly dividend of $1.65 per share declared.
- CEO cites economic headwinds, cost initiatives; new OPTA VIA ACTIVE line launched.

## SEC filing metadata
- accession: 0001628280-23-027839
- form_type: 8-K
- ticker: MED
- cik: 0000910329
- company_name: MEDIFAST INC
- filed_at: 2023-08-07T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/910329/000162828023027839/0001628280-23-027839-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/910329/000162828023027839/med-20230807.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-23-027839
- JSON: https://secwatch.observer/filing/0001628280-23-027839.json
- Plain text: https://secwatch.observer/filing/0001628280-23-027839.txt

## Key facts
- Earnings Releases
  MEDIFAST INC reported second quarter ended June 30, 2023 results: revenue $296.2 million, net income $30.3 million, EPS $2.77 per diluted share.
  - Period: second quarter ended June 30, 2023
  - Revenue: $296.2 million
  - Net income: $30.3 million
  - EPS: $2.77 per diluted share
  - Result: reported results
  source text: known for its habit-based and Coach-guided lifestyle solution, OPTA VIA® , today reported results for the second quarter ended June 30, 2023 . Second Quarter 2023 • Revenue of $296.2 million, with revenue per active earning coach of $5,578 • Independent active earning OPTA VIA Coaches of 53,100 • Net income of $30.3 million • Earnings per diluted share ("EPS) of
  evidence_url: https://www.sec.gov/Archives/edgar/data/910329/000162828023027839/0001628280-23-027839-index.htm
- Earnings Releases
  MEDIFAST INC reported third quarter 2023 results: revenue $220 million to $240 million, EPS $0.71 to $1.32. Guidance initiated.
  - Period: third quarter 2023
  - Revenue: $220 million to $240 million
  - EPS: $0.71 to $1.32
  - Guidance: initiated
  - Result: guidance update
  source text: The Company expects third quarter 2023 revenue to be in the range of $220 million to $240 million and third quarter 2023 diluted EPS to be in the range of $0.71 to $1.32
  evidence_url: https://www.sec.gov/Archives/edgar/data/910329/000162828023027839/0001628280-23-027839-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.